$2.00-2.50 is good (but considering there was a $10.00 in between means the jury is still out (
as is the case with many Biotechs)
You may be right -the best may still be coming.--but the example needed clarifying as it was misleading in terms of what we could maybe expect.
Im not even discounting the fact that (in these cases) there could be money made on sentiment alone,even if the company never actually makes it in terms of operating cash flow. A positive EPS (from grants and cap raisings)can be a dangerous thing if operating cash flow is negative.
We will have to wait and see if these new developments are a catalyst---Friday liked it.
(I must say,I thought the hair tonic would have given it more legs---worth more marketing?)
Bookmarks